Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Lubenow

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
New developments in diagnosis and treatment of heparin-induced thrombocytopeniaNorbert Lubenow
Seminars in Thrombosis and Hemostasis|November 7, 2002
Hirudin in heparin-induced thrombocytopeniaNorbert Lubenow, Andreas Greinacher
Lakartidningen|March 15, 2021
[Awareness of risk for transfusion reactions important for appropriate treatment]Norbert Lubenow, Marja-Kaisa Auvinen
Transfusion|February 17, 2015
Green plasmaDavid Berglund, Pernilla Lindvall, Norbert Lubenow
Lakartidningen|March 14, 2018
Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 yearsHonar Cherif, Andreas Greinacher, Norbert Lubenow
Blood|September 27, 2003
Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudinPetra Eichler, Norbert Lubenow, Ulrike Strobel, et al.
European Journal of Haematology|July 28, 2007
Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?Norbert Lubenow, Peter Hinz, Axel Ekkernkamp, et al.
Thrombosis and Haemostasis|March 27, 2004
Heparin-induced thrombocytopenia in children: 12 new cases and review of the literatureAnne F Klenner, Norbert Lubenow, Ricarda Raschke, et al.
Blood|July 29, 2004
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studiesNorbert Lubenow, Petra Eichler, Theresia Lietz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|November 5, 2016
Analysis of thromboelastography, PT, APTT and fibrinogen in intraosseous and venous samples-an experimental studyGunnar Strandberg, Miklós Lipcsey, Mats Eriksson, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
New developments in diagnosis and treatment of heparin-induced thrombocytopeniaNorbert Lubenow
Seminars in Thrombosis and Hemostasis|November 7, 2002
Hirudin in heparin-induced thrombocytopeniaNorbert Lubenow, Andreas Greinacher
Lakartidningen|March 15, 2021
[Awareness of risk for transfusion reactions important for appropriate treatment]Norbert Lubenow, Marja-Kaisa Auvinen
Transfusion|February 17, 2015
Green plasmaDavid Berglund, Pernilla Lindvall, Norbert Lubenow
Lakartidningen|March 14, 2018
Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 yearsHonar Cherif, Andreas Greinacher, Norbert Lubenow
Blood|September 27, 2003
Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudinPetra Eichler, Norbert Lubenow, Ulrike Strobel, et al.
European Journal of Haematology|July 28, 2007
Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?Norbert Lubenow, Peter Hinz, Axel Ekkernkamp, et al.
Thrombosis and Haemostasis|March 27, 2004
Heparin-induced thrombocytopenia in children: 12 new cases and review of the literatureAnne F Klenner, Norbert Lubenow, Ricarda Raschke, et al.
Blood|July 29, 2004
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studiesNorbert Lubenow, Petra Eichler, Theresia Lietz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|November 5, 2016
Analysis of thromboelastography, PT, APTT and fibrinogen in intraosseous and venous samples-an experimental studyGunnar Strandberg, Miklós Lipcsey, Mats Eriksson, et al.
Pageof 4